The Regulation of UK Aesthetic Medicine: Why Are Patients Still Waiting?

Patient Safety
Written By Dr Peter Forrester

The risks have been recognised. Parliament has provided the means to regulate. Government has consulted. The proposed safeguards are broadly understood. So why, in 2026, are patients still waiting for meaningful regulation of non-surgical aesthetic treatments?

An industry that has outgrown its oversight

The UK aesthetic medicine industry has grown at a remarkable pace over the past two decades. What was once a relatively niche field, practised predominantly by medically trained professionals, has become a vast and highly commercial marketplace.

Today, the sector encompasses everyone from consultant plastic surgeons and experienced aesthetic doctors to practitioners with no medical background at all.

The regulatory framework has not kept pace.

Successive governments have acknowledged the problem. Reviews have been commissioned, consultations held and proposals developed. Parliament has even provided the legislative mechanism through which a licensing scheme could be introduced.

Yet patients are still waiting for a comprehensive system that establishes consistent minimum standards for who may perform these procedures, what training they must have, where treatments may take place and what protections must exist when something goes wrong.

That is increasingly difficult to justify.

Who can perform aesthetic treatments in the UK?

This remains one of the most surprising aspects of aesthetic medicine for many patients.

The fact that a procedure involves injecting a substance into someone's face does not, by itself, mean that the person performing it must be a doctor, nurse or other regulated healthcare professional.

This distinction matters particularly with dermal fillers.

These treatments may be described as “non-surgical”, but that should never be confused with “without risk”. Complications can include infection, tissue damage and vascular occlusion. In rare but devastating circumstances, interruption of the blood supply associated with filler injection can result in permanent injury, including visual loss. Read about the potentially devastating complication - vascular occlusion.

Recognising a complication quickly, understanding the relevant anatomy and knowing how to respond are therefore not peripheral skills. They are fundamental to safe practice.

Yet there remains no comprehensive statutory licensing system operating across the sector that ensures every practitioner offering these treatments meets a common clinical standard.

The peculiar paradox: regulating the already regulated

This produces one of the strangest features of the current system.

Doctors, nurses and other regulated healthcare professionals are already identifiable and accountable.

Doctors practising aesthetic medicine remain subject to the standards of the General Medical Council. Nurses remain accountable to the Nursing and Midwifery Council. Their registration can be checked by members of the public, and serious failures of professional conduct can have consequences extending far beyond their aesthetic practice.

That does not mean medical practitioners cannot make mistakes. Of course they can.

It means there is an established framework within which their competence and conduct can be examined and, where appropriate, sanctioned.

An individual operating outside a regulated healthcare profession does not necessarily sit within an equivalent system of professional accountability.

That is the paradox at the heart of the debate.

The people who are easiest to regulate are often those who are already regulated. The challenge has always been how to establish meaningful and enforceable standards across the remainder of an enormous and fragmented industry.

Understand how to choose a safe aesthetic practitioner?

The insurance and patient-redress problem

There is another aspect of this debate that receives far less public attention than it deserves: what happens to the patient after something has gone wrong?

Professional accountability is one part of patient protection. Appropriate indemnity or insurance is another.

Regulated healthcare professionals are subject to professional requirements concerning appropriate indemnity arrangements for their practice. Patients therefore have a much clearer framework of accountability when treatment is provided within regulated medical practice.

Across the wider aesthetics sector, those protections have not historically been consistent.

This matters because compensation is not an abstract legal consideration when somebody has suffered a serious complication. A patient may require corrective treatment, specialist medical care, time away from work or prolonged management of physical and psychological consequences.

A regulatory system concerned with patient safety therefore cannot concentrate solely on who is permitted to hold a syringe.

It must also consider what protection exists for the patient when treatment causes harm.

Indeed, appropriate indemnity cover has formed part of the government's proposed approach to licensing. The fact that this safeguard has been contemplated illustrates precisely why the present gap matters.

More than a decade of reviews and consultations

None of this is new.

In 2013, the Keogh Review examined the regulation of cosmetic interventions and identified significant weaknesses in the way non-surgical cosmetic procedures were controlled.

Nearly a decade later, the Health and Care Act 2022 gave the Secretary of State powers to introduce a licensing scheme for specified non-surgical cosmetic procedures in England.

Government subsequently consulted in 2023 on how such a system might operate.

The proposed framework addressed many of the issues clinicians and patient-safety organisations had been raising for years. Who should be permitted to perform particular procedures, practitioner competence and training, standards for premises, infection control and hygiene, appropriate insurance arrangements, and how the system should be enforced.

The government eventually published its response to that consultation in August 2025. It had received 11,848 responses and reported widespread support for introducing regulation to improve public safety. But the response also acknowledged the considerable work still required to develop a practicable and proportionate licensing system.

That was progress.

But recognising a problem, consulting about a problem and possessing the legal power to address a problem are not the same thing as having an operational regulatory system.

As of 2026, patients are still waiting for the promised comprehensive licensing framework to become a practical reality.

Why has it taken so long?

There are legitimate difficulties involved in regulating this sector.

“Aesthetic medicine” covers a very broad range of procedures with very different risk profiles. Determining which treatments require which level of qualification is complicated. Training standards need to be defined. Existing professional regulation needs to interact sensibly with any new licensing system. Local authorities require workable enforcement powers and adequate resources.

Poorly designed regulation could create its own problems.

But complexity cannot indefinitely become an explanation for inaction.

The central principle is not complicated: a patient undergoing an invasive aesthetic procedure should be entitled to expect that the person treating them is appropriately trained, understands the risks, can recognise and manage complications, works in a suitable environment and has appropriate arrangements in place should harm occur.

After more than a decade of reviews, consultations and proposals, that does not seem an unreasonable expectation.

Patients ultimately carry the risk

Regulatory debates can easily become discussions about frameworks, qualifications and professional boundaries.

It is worth remembering who ultimately bears the consequences when those systems fail.

The patient does.

A vascular occlusion that is not recognised promptly is not a regulatory abstraction. Neither is an infection that goes untreated, inappropriate product placement, poor complication management or permanent scarring.

Nor is the distress of discovering, after something has gone badly wrong, that the person responsible may have limited clinical training, no meaningful professional accountability and inadequate financial provision for a claim.

The overwhelming majority of people seeking aesthetic treatment are not experts in medical regulation. Nor should they need to be.

A reasonable regulatory system should provide a baseline of protection before the patient walks through the door.

What should responsible regulation achieve?

The objective should not be to protect doctors from competition or to make aesthetic medicine the exclusive territory of one professional group.

It should be to protect patients.

A credible licensing framework should establish clear minimum standards appropriate to the risk of the procedure being performed. It should require practitioners to demonstrate appropriate training and competence. Premises should meet defined standards for safety, hygiene and infection control.

Practitioners should have appropriate and compulsory insurance arrangements, and the system must contain meaningful enforcement mechanisms for those who choose to operate outside it.

There should also be clarity for patients.

A member of the public ought to be able to establish easily whether a practitioner is appropriately qualified or licensed, whether a healthcare professional's registration is genuine and what route to redress exists if something goes wrong.

These are not extravagant protections.

They are the sort of safeguards patients reasonably assume already exist.

Why this matters to us

We do not raise this issue because we believe that possessing a medical degree automatically makes somebody a good aesthetic practitioner. It does not.

Nor do we raise it simply to position doctors favourably against non-medical competitors.

We raise it because we are doctors working in aesthetic medicine and we see patient safety as inseparable from the way our industry develops.

Read about our philosophy at the Cosmetic Doctors Company.

Aesthetic medicine is capable of delivering excellent outcomes. Treatments can be performed carefully, ethically and with a very high standard of clinical judgement. But describing these procedures as “non-surgical” should never allow us to pretend that they are trivial.

Patients deserve to know that the person treating them is competent.

They deserve to know that somebody is accountable.

And they deserve to know that if something does go wrong, a meaningful system exists to protect them.

Government has recognised the problem. Parliament has provided the mechanism. Consultation has demonstrated the appetite for change.

The question in 2026 is no longer whether the aesthetic sector requires better regulation . . . .

. . . . it is why patients are still waiting for it.

References and Further Reading

Dr Peter Forrester

Dr Peter Forrester is Medical Director of The Cosmetic Doctors Company in Esher, Surrey. He has practised aesthetic medicine for over 25 years and has extensive experience in non-surgical facial rejuvenation.

GMC reference number: 2375232
GMC Specialist Register

Next

How Do I Choose a Sunscreen?